Dergi makalesi Açık Erişim

AMG-176, an Mcl-1 Antagonist, Shows Preclinical Efficacy in Chronic Lymphocytic Leukemia

   Yi, Xue; Sarkar, Aloke; Kismali, Gorkem; Aslan, Burcu; Ayres, Mary; Iles, LaKesla R.; Keating, Michael J.; Wierda, William G.; Long, James P.; Bertilaccio, Maria Teresa Sabrina; Gandhi, Varsha

Purpose: Survival of CLL cells due to the presence of Bcl-2 and Mcl-1 has been established. Direct inhibition of Bcl-2 by venetoclax and indirect targeting of Mcl-1 with transcription inhibitors have been successful approaches for CLL. AMG-176 is a selective and direct antagonist of Mcl-1, which has shown efficacy in several hematologic malignancies; however, its effect on CLL is elusive. We evaluated biological and molecular effects of AMG-176 in primary CLL cells.

Dosyalar (271 Bytes)
Dosya adı Boyutu
bib-1446e4a1-d9c7-48b2-9bd4-34d39463549d.txt
md5:1aebdb567673f110f890b2e4e24a3edb
271 Bytes İndir
28
8
görüntülenme
indirilme
Görüntülenme 28
İndirme 8
Veri hacmi 2.2 kB
Tekil görüntülenme 27
Tekil indirme 8

Alıntı yap